RxDoctor Payments Data

Elisa Contreras

Family · Sebring, FLNPI 1184194342

Payments from drug & device makers

$12,602in general payments, 2019–2025

Across 599 payments — averaging $21.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Novartis$1K
  • AstraZeneca$930
  • E.r. Squibb & Sons, L.L.C.$720
  • Incyte Corporation$596
  • Bayer$589
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$11,22389%
  • Education$8807%
  • Other$4994%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson79$1,407
Novartis51$1,152
AstraZeneca(2 entities)47$930
E.r. Squibb & Sons, L.L.C.39$720
Incyte Corporation25$596
Bayer35$589
Merck25$540
Pfizer24$475
Bristol Myers Squibb18$434
Lilly USA, LLC15$396
Seagen Inc.14$387
Daiichi Sankyo Inc.13$309
Takeda Pharmaceuticals U.S.A., Inc.13$279
Gilead13$263
Sobi, Inc11$242
Eisai Inc.13$237
Sanofi-aventis U.S. LLC2$198
GSK9$197
AbbVie8$192
Ipsen Biopharmaceuticals, Inc4$188
Array Biopharma Inc10$184
Genentech USA, Inc.9$176
Amgen8$173
Astellas Pharma US Inc9$163
Tersera Therapeutics LLC7$135
Sanofi7$133
Exelixis Inc.2$119
Pharmaessentia USA Corporation5$114
Kyowa Kirin, Inc.5$110
Taiho Oncology, Inc.5$106
Morphosys, US Inc.5$89
Pharmacyclics LLC, An Abbvie Company4$88
EMD Serono, Inc.4$87
Pharmacosmos Therapeutics Inc.3$79
Deciphera Pharmaceuticals Inc.4$79
Geron Corporation3$66
Puma Biotechnology, Inc.4$62
Apellis Pharmaceuticals, Inc.3$61
Mirati Therapeutics, Inc.3$58
Dendreon Pharmaceuticals LLC2$45
Jazz Pharmaceuticals Inc.2$43
Dova Pharmaceuticals2$43
Karyopharm Therapeutics Inc.2$42
Myovant Sciences Inc.2$39
Sumitomo Pharma America, Inc.2$35
Genmab U.S., Inc.2$35
Foundation Medicine, Inc.2$34
Stemline Therapeutics Inc.2$33
Servier Pharmaceuticals LLC2$32
Legend Biotech USA Inc.1$30
Regeneron Healthcare Solutions, Inc.1$29
CTI Biopharma Corp.1$26
GE HealthCare1$25
Fennec Pharmaceuticals, Inc.1$25
Acrotech Biopharma Inc.1$24
Myriad Genetic Laboratories, Inc.1$22
Azurity Pharmaceuticals, Inc.1$21
AVEO Pharmaceuticals, Inc.1$18
Tolmar, Inc.1$18
Acceleron Pharma, Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,602 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydroxyurea12$583
Anastrozole17$139

Paid to pharmacies, not to this prescriber.

Other family in Sebring

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →